Hims & Hers Health, INC Form 4 insider transactions

Hims & Hers Health, Inc. has granted 526,711 Restricted Stock Units to Chief Policy Officer Deborah M. Autor, vesting over four years.

Hims & Hers Health, Inc. Director and Chief Medical Officer Patrick Harrison Carroll was granted 150,489 Restricted Stock Units, vesting over four years.

Hims & Hers Health, Inc.'s Chief Legal Officer, Soleil Boughton, was granted 188,111 Restricted Stock Units subject to a four-year service-based vesting schedule.

Hims & Hers Health, Inc. CTO Mohamed Elshenawy was granted 376,222 Restricted Stock Units, vesting over four years.

Hims & Hers Health, Inc. CEO Andrew Dudum was granted 413,844 Restricted Stock Units, vesting over four years starting June 2026.

Hims & Hers Health, Inc. Chief Financial Officer Oluyemi Okupe was granted 300,978 Restricted Stock Units, vesting over four years.

Hims & Hers Health, Inc.'s Chief Financial Officer, Oluyemi Okupe, earned 410,690 shares of Class A Common Stock through performance-based restricted stock units.

Hims & Hers Health, Inc.'s Chief Legal Officer, Soleil Boughton, earned 273,794 shares of Class A common stock through performance-based restricted stock units.

Hims & Hers Health, Inc.'s Chief Operating Officer, Michael Chi, earned 365,058 performance-based restricted stock units, reflecting met performance criteria.

Hims & Hers Health, Inc. CEO Andrew Dudum acquired 794,002 Class A common shares after performance criteria for restricted stock units were met.

Hims & Hers Health, Inc. CFO Oluyemi Okupe exercised stock options and immediately sold an equal number of Class A Common Stock shares under a pre-arranged 10b5-1 trading plan.

Hims & Hers Health, Inc. CFO Oluyemi Okupe exercised stock options and subsequently sold a portion of Class A Common Stock under a pre-arranged 10b5-1 trading plan.

Hims & Hers Health, Inc.'s Chief Financial Officer, Oluyemi Okupe, executed planned stock option exercises and subsequent share sales on January 5, 2026.

Hims & Hers Health, Inc.'s Chief Financial Officer, Oluyemi Okupe, sold 23,090 shares of Class A Common Stock for an average price of $35.7172 per share.

Hims & Hers Health, Inc. Chief Operating Officer Michael Chi sold 13,750 shares of Class A Common Stock for $36.71 per share.

Hims & Hers Health, Inc. Chief Policy Officer Deborah M. Autor sold 7,054 shares of Class A Common Stock for $36.71 per share.

Hims & Hers Health, Inc. Chief Medical Officer Patrick Harrison Carroll sold 10,021 shares of Class A Common Stock for $36.71 per share under a pre-arranged trading plan.

Hims & Hers Health, Inc. officer Irene Becklund sold 8,411 shares of Class A Common Stock for $36.71 per share, as part of a pre-arranged trading plan.

Hims & Hers Health, Inc.'s Chief Legal Officer, Soleil Boughton, reported the vesting and exercise of Restricted Stock Units and the sale of shares to cover tax obligations.

Hims & Hers Health, Inc. Chief Medical Officer Patrick Harrison Carroll reported the vesting of restricted stock units and subsequent tax-related share disposals.

Hims & Hers Health, Inc. CEO Andrew Dudum reported the vesting of Restricted Stock Units and related tax withholding transactions on December 15, 2025.

Hims & Hers Health, Inc. PAO Irene Becklund reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations on December 15, 2025.

Hims & Hers Health, Inc. CFO Oluyemi Okupe reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations on December 15, 2025.

Hims & Hers Health, Inc. Chief Operating Officer Michael Chi reported the vesting of 72,106 restricted stock units and the subsequent sale of 39,870 shares to cover tax obligations.

Hims & Hers Health, Inc. Chief Policy Officer Deborah M. Autor converted 7,054 Restricted Stock Units into Class A Common Stock.

Hims & Hers Health, Inc. Director Andrea G Perez Garcia sold 2,500 shares of Class A Common Stock for $39.17 per share on December 9, 2025.

Hims & Hers Health, Inc. CEO Andrew Dudum reported several beneficial ownership changes involving transfers of Class A Common Stock between various family trusts and his direct holdings.

Hims & Hers Health, Inc. Chief Operating Officer Michael Chi reported gifting 5,000 shares of Class A Common Stock to a Donor Advised Fund.

Hims & Hers Health, Inc.'s Chief Legal Officer, Soleil Boughton, sold 2,631 shares of Class A Common Stock for $35.22 per share under a pre-arranged trading plan.

Hims & Hers Health, Inc. CFO Oluyemi Okupe exercised stock options and subsequently sold 23,187 shares of Class A Common Stock for approximately $36.81 per share.